| Indicators | Browse All

Femasys Inc. (FEMY)

Healthcare | Medical Instruments & Supplies | Suwanee, United States | NasdaqCM
1.65 USD -0.09 (-4.899%) ⇩ (Oct. 16, 2026, 4 p.m. EDT)

Short-term:⯪☆☆☆☆Long-term:⯪☆☆☆☆Dividends:☆☆☆☆☆
Hot Take ↕ | Oct. 10, 2026, 6 a.m. EDT

The immediate outlook is severely bearish due to a confluence of deteriorating fundamentals and aggressive capital dilution. The company is generating significant negative free cash flow and operating losses while facing a massive debt burden relative to equity, creating a precarious balance sheet. Compounding this distress, the recent announcement of a 1-for-20 reverse split alongside a public offering priced at a steep discount signals deep liquidity issues and a desperate attempt to raise capital, which typically depresses share prices further. While the price-to-book ratio appears mathematically attractive at 1.5x, this is a false signal given the negative earnings and the fact that the market is pricing in a severe impairment of the business model. The statistical forecast model also leans negative for the coming month, aligning with the fundamental deterioration. There is no dividend to provide income, and the combination of shrinking revenues, mounting debt, and equity dilution makes this a high-risk speculative vehicle rather than an investment.

Model Selection — Backtest MAE (log-scale, lower is better)
ModelMAE
AutoETS ✓0.175410
MSTL0.179184
AutoTheta0.253048
AutoARIMA0.441374

Forecast horizon: 45 days | Selected: AutoETS

Forecast Reliability
Score 35%
H-stat 0.63
Ljung-Box p 0.000
Jarque-Bera p 0.341
Excess Kurtosis -0.60
Attribute Value
Sector Healthcare
Debt to Equity Ratio 118.837
Revenue per Share 0.773
Market Cap 13,818,794
Forward P/E -0.78
Beta -2.16
Website https://femasys.com

Info Dump

Attribute Value
52 Week Change -0.8627288
Address1 3,950 Johns Creek Court
Address2 Suite 100
All Time High 275.0
All Time Low 1.46
Ask 2.59
Ask Size 2
Average Analyst Rating 1.7 - Buy
Average Daily Volume10 Day 102,920
Average Daily Volume3 Month 729,043
Average Volume 729,043
Average Volume10Days 102,920
Beta -2.155
Bid 2.01
Bid Size 1
Book Value 1.333
City Suwanee
Compensation As Of Epoch Date 1,767,139,200
Country United States
Crypto Tradeable 0
Currency USD
Current Price 1.65
Current Ratio 2.144
Custom Price Alert Confidence HIGH
Date Short Interest 1,790,726,400
Day High 1.77
Day Low 1.6
Debt To Equity 118.837
Display Name Femasys
Dividend Yield 0.0
Ebitda -17,229,926
Ebitda Margins 0.0
Enterprise To Ebitda -0.996
Enterprise To Revenue 7.465
Enterprise Value 17,165,538
Eps Forward -2.125
Eps Trailing Twelve Months -3.28
Esg Populated 0
Exchange NCM
Exchange Data Delayed By 15
Exchange Timezone Name America/New_York
Exchange Timezone Short Name EDT
Fax 404 581 5903
Fifty Day Average 2.4708
Fifty Day Average Change -0.82079995
Fifty Day Average Change Percent -0.33220008
Fifty Two Week Change Percent -86.27288
Fifty Two Week High 22.2
Fifty Two Week High Change -20.550001
Fifty Two Week High Change Percent -0.9256757
Fifty Two Week Low 1.46
Fifty Two Week Low Change 0.18999994
Fifty Two Week Low Change Percent 0.13013694
Fifty Two Week Range 1.46 - 22.2
Financial Currency USD
First Trade Date Milliseconds 1,624,023,000,000
Float Shares 7,347,579
Forward Eps -2.125
Forward P E -0.7764706
Free Cashflow -11,230,021
Full Exchange Name NasdaqCM
Full Time Employees 51
Fullday Change -0.08500004
Fullday Change Percent -4.843307
Fullday Price 1.65
Gmt Off Set Milliseconds -14,400,000
Gross Margins 0.60948
Gross Profits 1,401,492
Has Pre Post Market Data 1
Held Percent Insiders 0.03923
Held Percent Institutions 0.52839
Implied Shares Outstanding 8,375,027
Industry Medical Instruments & Supplies
Industry Disp Medical Instruments & Supplies
Industry Key medical-instruments-supplies
Ipo Expected Date 2,021-06-18
Language en-US
Last Fiscal Year End 1,767,139,200
Last Split Date 1,780,876,800
Last Split Factor 1:20
Long Business Summary Femasys Inc., a biomedical company, develops and commercializes therapeutic and diagnostic products for women's reproductive health needs in the United States and internationally. The company offers FemaSeed, an intratubal insemination device; FemVue, a companion diagnostic for fallopian tube assessment through ultrasound; FemSperm, a sperm handling kit; FemChec, a confirmation test for tubal patency; FemCerv, an endocervical tissue sampler for cervical cancer diagnosis; and FemCath, a cornual balloon catheter for selective tube evaluation. It also provides FemBloc, a non-surgical female permanent birth control solution. The company offers its products to gynecological physicians, related healthcare professionals, and women's healthcare provider organizations. Femasys Inc. was incorporated in 2004 and is headquartered in Suwanee, Georgia.
Long Name Femasys Inc.
Market us_market
Market Cap 13,818,794
Market State CLOSED
Max Age 86,400
Message Board Id finmb_61212730
Most Recent Quarter 1,782,777,600
Net Income To Common -11,768,121
Next Fiscal Year End 1,798,675,200
Non Diluted Market Cap 21,272,568
Number Of Analyst Opinions 3
Open 1.7
Operating Cashflow -17,651,812
Operating Margins -15.26661
Phone 770 500 3910
Previous Close 1.735
Price Hint 4
Price To Book 1.2378095
Price To Sales Trailing12 Months 6.0094857
Profit Margins 0.0
Quick Ratio 0.41
Quote Source Name Delayed Quote
Quote Type EQUITY
Recommendation Key buy
Recommendation Mean 1.66667
Region US
Regular Market Change -0.085
Regular Market Change Percent -4.89914
Regular Market Day High 1.77
Regular Market Day Low 1.6
Regular Market Day Range 1.6 - 1.77
Regular Market Open 1.7
Regular Market Previous Close 1.735
Regular Market Price 1.65
Regular Market Time 1,792,180,801
Regular Market Volume 58,520
Return On Assets -0.84225
Return On Equity -4.24966
Revenue Growth -0.189
Revenue Per Share 0.773
Sand P52 Week Change 0.13723719
Sector Healthcare
Sector Disp Healthcare
Sector Key healthcare
Shares Outstanding 8,375,027
Shares Percent Shares Out 0.0689
Shares Short 577,249
Shares Short Previous Month Date 1,788,134,400
Shares Short Prior Month 593,056
Short Name Femasys Inc.
Short Percent Of Float 0.0701
Short Ratio 6.9
Source Interval 15
State GA
Symbol FEMY
Target High Price 23.0
Target Low Price 10.0
Target Mean Price 14.33333
Target Median Price 10.0
Total Cash 1,443,502
Total Cash Per Share 0.172
Total Debt 4,790,245
Total Revenue 2,299,497
Tradeable 0
Trailing Annual Dividend Rate 0.0
Trailing Annual Dividend Yield 0.0
Trailing Eps -3.28
Trailing Peg Ratio None
Triggerable 1
Two Hundred Day Average 6.6655
Two Hundred Day Average Change -5.0155
Two Hundred Day Average Change Percent -0.75245667
Type Disp Equity
Volume 58,520
Website https://femasys.com
Zip 30,024